The short version of modified GRF(1-29) fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C152H252N44O42 | Cited for the form without the drug affinity complex |
| Molecular weight | About 3368 Da | Reported value for modified GRF(1-29) |
| Appearance | White to off-white powder | Lyophilised solid as usually supplied |
| Solubility | Soluble in water and polar solvents | Clarity depends on purity and salt content |
| Typical storage | -20 C or below, dry | Protect from light and repeated warming cycles |
The dividing feature between the two forms is a maleimide-based drug affinity complex, abbreviated DAC. In the DAC-bearing version, a linker attaches the peptide to serum albumin after administration, and that association slows removal from plasma. The version lacking DAC appears in catalogs as MOD GRF(1-29) or tetrasubstituted GRF(1-29). Because informal writing treats both as one item, comparisons drawn from such sources routinely blend measurements taken from two molecules with substantially different behavior.
Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, constructed on the 29-amino-acid fragment designated GRF(1-29). The name began as an internal development code during the 1990s and later spread through research supply catalogs and discussion forums. The molecule does not occur in nature; its sequence is engineered rather than isolated from tissue. Two related compounds are sold under this single label, and they differ by one appended chemical group that strongly influences how long the peptide remains in circulation.
The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.
Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.
Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.
Lyophilized material is typically stored at minus twenty degrees Celsius or lower. Keeping the vial dry and protected from light preserves peptide integrity. Repeated freeze-thaw cycles can cause aggregation or loss of activity. Once dissolved, solutions are generally kept at two to eight degrees Celsius. Stability data for reconstituted solutions vary, and long-term behavior is not fully established. Working aliquots reduce the number of times a stock container is opened.
Reverse-phase high-performance liquid chromatography is the standard tool for purity assessment. The technique separates the target peptide from truncated or modified byproducts. Mass spectrometry confirms molecular weight and supports sequence verification. Electrospray ionization and matrix-assisted laser desorption are both used. Amino acid analysis provides an independent check on composition. Purity values are commonly reported as area percentage from the chromatogram. Residual trifluoroacetate and water content are also measured in many quality programs.
Batch-to-batch consistency depends on solid-phase peptide synthesis and subsequent purification. Coupling efficiency, resin choice, and cleavage conditions all affect the final profile. Counter-ion content and moisture can shift the apparent mass of a batch. Documentation typically includes a certificate of analysis with chromatograms and spectra. Independent verification by a second laboratory is sometimes requested. Whether a given certificate reflects the actual vial contents depends on chain of custody. Analytical methods themselves carry uncertainty that should be stated alongside results.
=== Nicole Craig === Nicole Craig (Sarah Parish) is the CEO of investment fund Mallon Mercer, and a major Pierpoint client. Despite being an outspoken feminist in public, she repeatedly engages in predatory sexual behavior toward junior bankers. In series 1, Nicole makes a drunken sexual advance on graduate Harper Stern following a client dinner. Harper initially maintains the relationship to protect her job but later deliberately antagonizes Nicole into severing ties with Pierpoint. In series 2, Robert, looking to make more outgoing calls, wins Nicole back as a Pierpoint client by being endearingly honest about feeling out of his depth at the job. The two connect over dinner, and Nicole masturbates him in the car on the way home. The two continue an illicit sexual relationship for months onward, with Robert projecting many of his unresolved issues with his late mother onto the domineering Nicole. Robert later learns from Harper that Nicole made an advance on her the previous year. Nicole later sexually assaults new hire Venetia Berens, who Robert left alone with Nicole during a client dinner that went sideways. Venetia’s attempt to report the incident is suppressed by Pierpoint management. Robert tries to cut ties with Nicole afterwards, but she reestablishes her control over him after bailing him out when he is arrested for cocaine possession. In series 3, Robert and Nicole are still involved; Robert spends a night with her, only to suddenly find her dead the next morning.
Meso-zeaxanthin (3R,3′S-zeaxanthin) is a xanthophyll carotenoid, and is one of the three stereoisomers of zeaxanthin. The meso- form is the second most abundant in nature, after 3R,3′R-zeaxanthin, which is produced by plants and algae. Meso-zeaxanthin has been identified in specific tissues of marine organisms and in the macula lutea, also known as the "yellow spot" of the human retina.
In microfluidic Sanger sequencing the entire thermocycling amplification of DNA fragments as well as their separation by electrophoresis is done on a single glass wafer (approximately 10 cm in diameter) thus reducing the reagent usage as well as cost. In some instances researchers have shown that they can increase the throughput of conventional sequencing through the use of microchips. Research will still need to be done in order to make this use of technology effective.
Sources: en.wikipedia.org
=== Release === Tau is involved in uptake and release processes, which are known as seeding. Uptake of tau protein requires the presence of heparan sulfate proteoglycans at the cell surface, which happens by macropinocytosis. On the other hand, tau release depends on neuronal activity. Many factors influence tau release such as, for example, the isoforms or MAPT mutations that change the extracellular level of tau. According to Asai and his colleagues, the spreading of tau protein occurs from the entorhinal cortex to the hippocampal region in the early stages of the disease. They also suggested that microglia were also involved in the transport process, and their actual role is still unknown.
== Chemistry == The naphthoquinones lawsone, or hennotannic acid, and lawsone methyl ether and methylene-3,3'-bilawsone are some of the active compounds in I. balsamina leaves. It also contains kaempferol and several derivatives. Baccharane glycosides have been found in Chinese herbal remedies made from the seeds.
Lauer of the Kitt Peak National Observatory; the Hubble constant was determined from supernovae, known as standard candles or the cosmic distance ladder; Fermilab thought the age of the universe was around 20 billion years, which would imply a low Hubble constant; helioseismology was a new method; astrophysicist Michael Rowan-Robinson of Imperial College; French Pierre Lamarque and the age of globular clusters; astrophysicist Simon White of the University of Cambridge, and how the Moon weighs 80 times less than the Earth; John Huchra; physicist Neil Turok of Princeton University and physicist Alan Guth of MIT, and the universe's density parameter Ω, calculated from the Friedmann equations; Mexican Carlos Frenk of Durham University; the higher the Hubble constant, a conventional explanation of the Big Bang was more difficult; Jim Peebles of Princeton University; physicist Frank Close and perception of time. Narrated by Charlotte Cornwell. Part of the programme led to The Time Machine (Alan Parsons album) in 1999 (Parsons also made the music for the episode). Directed by Storm Thorgerson, produced by Geoff Deehan, made by Union Pictures 16 October Hypnosis - The Big Sleep, with Nicholas Spanos of Canada, and John Gruzelier and Graham Wagstaffe of the University of Liverpool; the documentary has scenes of gruesome medical procedures; Australian John Gruzelier of Charing Cross and Westminster Medical School; the 1923 poem Stopping by Woods on a Snowy Evening by Robert Frost; Helen Crawford of Virginia State University, and chronic pain and evoked potential; Karl H.
Alkanes form a small portion of the atmospheres of the outer gas planets such as Jupiter (0.1% methane, 2 ppm ethane), Saturn (0.2% methane, 5 ppm ethane), Uranus (1.99% methane, 2.5 ppm ethane) and Neptune (1.5% methane, 1.5 ppm ethane). Titan (1.6% methane), a satellite of Saturn, was examined by the Huygens probe, which indicated that Titan's atmosphere periodically rains liquid methane onto the moon's surface. Also on Titan, the Cassini mission has imaged seasonal methane/ethane lakes near the polar regions of Titan. Methane and ethane have been detected in the tail of the comet Hyakutake. Chemical analysis showed that the abundances of ethane and methane were roughly equal, which is thought to imply that its ices formed in interstellar space, away from the Sun, which would have evaporated these volatile molecules. Alkanes have been detected in meteorites such as carbonaceous chondrites.
Sources: en.wikipedia.org
Gwen Chambers (Rose Abdoo) is a cancer patient who befriends and advises Kristina when Kristina is diagnosed with cancer. Gwen suffers a relapse of cancer and dies around the end of season 5. Kristina names the school she starts "Chambers Academy" in her honor. Dr. Bedsloe (Kurt Fuller) is the physician who performs Kristina's lumpectomy, recommends chemotherapy, and routinely checks up on her to see if the cancer is progressing or if she is cancer-free. Ruby Rizzoli (Courtney Grosbeck) is Hank Rizzoli's daughter, who is 14 in season 5. Sandy Rizzoli (Betsy Brandt) is Hank Rizzoli's former wife and the mother of Ruby Rizzoli. Oliver Rome (Tyson Ritter) is a musician who works for a fictional label in the show. He has his own band called Ashes of Rome. He is often egotistical and hotheaded. Carl Fletcher (Josh Stamberg) is a tenant in the building where Sarah Braverman lives and works as a super in season 5. Carl and Sarah have a brief relationship. Meredith Peet (Sonya Walger), known simply as "Peet", is the architect who hires Joel and his construction crew in season 5. Ed Brooks (David Denman) is a parent at the school Sydney and Victor Graham attend, who is on the sustainability committee with Julia. Their friendship starts to turn into an emotional affair that starts to get complicated when Ed kisses Julia, causing Joel to leave her. Heather Hall (Jurnee Smollett-Bell) is a smart and feisty up-and-coming political campaign adviser whom Kristina hires to be her campaign manager in season 5. Chad “Berto” Roberto (Nick Krause) is Drew's college roommate in season 5.
== Projects == Oncocheck ONCOCHECK is a set of clinical studies conducted by Life Length during 2017. The aim of the project was the clinical validation of telomere-associated variables (TAVs) as cancer biomarkers. It involved more than 1,200 adults and 300 children suffering from one of multiple existing types of cancer, including breast, prostate, lung, and leukemia cancers, among others. ONCOCHECK received funding from the European Union's Horizon 2020 research and innovation program. With more than 7,000 peer-reviewed scientific and clinical publications, telomere length measurement has established itself as a biomarker in cancer diagnosis and prognosis. This project has the invaluable support of some of the most important hospitals in Spain such as "University Hospital 12 de octubre", "University Hospital Puerta de Hierro", "University Hospital Niño Jesús", "Vall d'Hebron Hospital", and "Centro Integral Oncológico Clara Campal (CIOCC)". Within the ONCOCHECK project, Life Length is also conducting studies in advanced solid tumors and chronic lymphocytic leukemia (CLL). The results of the ONCOCHECK project have enabled Life Length to develop new applications in oncology . Prostate cancer diagnosis product Telomeres as cancer biomarkers: Tumor cells work differently from normal cells. As a cell becomes cancerous, it divides more frequently, and its telomeres shorten faster. Cancer cells avoid senescence/death and instead become immortal with the ability to replicate indefinitely, even when telomeres are short.
In protein mass spectrometry, tandem mass spectrometry (also known as MS/MS or MS2) experiments are used for protein/peptide identification. Peptide identification algorithms fall into two broad classes: database search and de novo search. The former search takes place against a database containing all amino acid sequences assumed to be present in the analyzed sample. In contrast, the latter infers peptide sequences without knowledge of genomic data.
Sources: en.wikipedia.org
It is a synthetic peptide analogue of growth hormone-releasing hormone. Four substitutions in its sequence make it more resistant to enzymatic degradation than the natural hormone. In the version carrying a drug affinity complex, the peptide binds albumin and remains in circulation for days.
No regulatory agency has approved CJC-1295 for clinical use. Human trials were conducted in the 2000s, but the development programme was discontinued before any marketing application succeeded. Material sold today is offered as a research chemical, and its purity depends on the supplier.
Sermorelin is an unmodified fragment of growth hormone-releasing hormone and is cleared quickly. CJC-1295 contains substitutions that resist breakdown, and the form with a drug affinity complex persists much longer. Both act at the same receptor but differ substantially in duration of action.
The two share the same 29-amino-acid backbone. CJC-1295 carries an additional albumin-binding moiety that markedly extends its residence time in circulation, while the form without that moiety clears faster. Literature sometimes applies the name loosely to either variant.